WMED .24 x .28 check this news, check filings, they already profitable last Q
Worldwide Medical Corp. Ships Initial New Distribution Orders for Its First Check Cholesterol Test to Target Stores Inc. Nationwide
LAKE FOREST, Calif.--(BW HealthWire)--July 10, 2002--Daniel G. Mc Guire, president and CEO of Worldwide Medical Corp. (OTC BB:WMED - News; www.wwmed.com), the exclusive marketer of First Check® branded home screening tests for drugs of abuse, alcohol, cholesterol and colorectal disease today announced that the company has secured a significant national distribution agreement with Target Stores Inc.
First Check cholesterol home screening tests are now available to be purchased in more than 650 Target Corporate retail stores in their pharmacy department.
Coronary Heart Disease is the leading cause of death in America today. Elevated levels of cholesterol play a significant role in as many as 50% of those deaths. The National Cholesterol Education Program recommends that all adults age 20 and over have their cholesterol measured periodically.
Mc Guire stated: "The company is very pleased to have our First Check home cholesterol screening tests available for purchase in the pharmacy department of Target Stores across the United States. The addition of Target stores to our growing national retailer distribution base will provide the company a 100% revenue increase in this all important growth segment (cholesterol) over the next 52 weeks."
Target is a national upscale discounter that provides quality merchandise in clean, spacious and guest-friendly stores. Target operates more than 1,081 stores in 47 states, including 75 SuperTarget stores. Target guests have a median age of 44 years, with above average household income, 80% female and approximately 43% are parents. Target has focused significant resources over the past year in developing their on-site pharmacy business.
Forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties, including, but not limited to, the results of research and development efforts, the effect of the United States Food and Drug Administration and other agencies, the impact of competitive products, access to capital, market demand for the company's products, changes in trade practices and the risk of trade practice litigation, technological changes, intellectual property rights, and other risks detailed from time to time in the company's reports.
--------------------------------------------------------------------------------
Contact:
Worldwide Medical Corp., Lake Forest
Daniel G. Mc Guire or Kevin Gadawski
949/598-8378
Fax: 949/598-8757 |
